Generali Asset Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.28M Sell
68,532
-10,485
-13% -$917K 0.11% 166
2026
Q1
$6.73M Sell
79,017
-7,265
-8% -$647K 0.14% 144
2025
Q4
$6.82M Buy
86,282
+10,447
+14% +$819K 0.14% 138
2025
Q3
$6.06M Sell
75,835
-25,971
-26% -$2.22M 0.13% 148
2025
Q2
$9.25M Buy
101,806
+36,072
+55% +$3.29M 0.21% 102
2025
Q1
$6.16M Sell
65,734
-23,421
-26% -$2.1M 0.15% 147
2024
Q4
$8.11M Buy
+89,155
New +$8.51M 0.21% 107

Other funds holding CL

Generali Asset Management's CL Position: Q2 2026 in Review

Generali Asset Management reduced its Colgate-Palmolive (CL) stake by 13% in Q2 2026, selling an estimated $917K and leaving 68,532 shares worth $6.28M. The position accounts for 0.11% of the portfolio, ranked #166.

Generali Asset Management first reported a position in CL in Q4 2024 and has held it in 7 quarters since. The position peaked at $9.25M in Q2 2025. 2,016 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Generali Asset Management held 68,532 shares of Colgate-Palmolive worth $6.28M as of Q2 2026.
  • Generali Asset Management sold 10,485 Colgate-Palmolive shares in Q2 2026, an estimated $917K.
  • Colgate-Palmolive made up 0.11% of Generali Asset Management's portfolio in Q2 2026, its #166 holding.
  • Generali Asset Management first reported a position in Colgate-Palmolive in Q4 2024 and has held it in 7 quarters since.
  • Generali Asset Management's Colgate-Palmolive position peaked at $9.25M in Q2 2025.
  • 2,016 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Generali Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.